ARWR September 18th Options Begin Trading

Arrowhead Pharmaceuticals (ARWR) options trades are presented as yield-enhancing strategies versus buying shares at $66.54. A $65 put trading with a $13 bid would obligate a buyer to purchase at $65, producing an effective cost basis of $52 and implying a 20.00% return (29.68% annualized) if the put expires worthless (current modeled odds 66%). On the call side, selling the $70 call with a $14 bid as a covered call would cap proceeds at $70 and deliver a 26.24% total return if called at the September 18 expiration, with a 39% chance of expiring worthless and a 21.04% yield boost (31.22% annualized). Implied volatilities are ~81% (put) and 79% (call) versus a 12-month realized volatility of 72%.

Analysis

Market structure: Option sellers and income-driven equity holders in ARWR are the immediate beneficiaries — selling the Sep18 $65 put ($13 bid) or $70 covered call ($14 bid) converts elevated implied vol (79–81%) into cash yields (20–21% over cash commitment, ~30% annualized). Buyers of uncapped upside lose optionality if covered calls scale; capital allocators seeking biotech exposure may favor yield over directional stakes. The implied vol premium ~7–10 pts over realized (81% vs 72%) signals modestly expensive tail insurance but not extreme dislocation, so flows favor volatility sellers until a binary event.

Risk assessment: Tail risk is binary clinical/regulatory outcomes that can move ARWR ±50%+ within days; a negative readout or partner termination is a high-impact low-probability event that can vaporize premium and spike IV >150%. Immediate (days) risk: gamma/assignment around Sep18 expiry; short-term (weeks/months): theta decay benefits sellers; long-term (quarters): pipeline milestones, cash runway, and partnership payments drive fundamentals. Hidden dependencies include milestone timing and partner option triggers — monitor cash burn and upcoming data windows within 30–90 days.

Trade implications: Lean defined-risk income strategies: cash-secured Sep18 $65 puts (collect $1,300/contract) sized 1–3% portfolio or 65/60 put spreads to cap downside (width $5 limits max loss to $500 less net credit; target net credit ≥$8). For stock exposure, buy 100 shares at ~$66.54 and sell Sep18 $70 calls to target ~26% gross return if called; hedge with $62–60 protective puts if unwilling to be assigned. Volatility play: buy a Sep18 straddle (cost ≈ $2,700) only around confirmed catalyst if expecting >40% move; otherwise sell premium with strict risk limits.

Contrarian angles: Consensus prize selling premium but underestimates assignment and capital lock-up risk — being assigned at $65 ties capital at a $52 breakeven (after premium), which may be poor if sector re-rates. The modest IV premium above realized suggests sellers are paid, but historical biotech binaries often produce >2x IV spikes and dramatic skew moves; prefer defined-risk spreads to naked positions. Liquidity/width risk in OTM strikes can widen during stress, so avoid outsized naked short positions without hedges.

Key Decisions for Investors

• Sell cash‑secured ARWR Sep18 65 put (collect ~$13 = $1,300 per contract), cap exposure to 1–3% of portfolio capital, set hard stop-loss/close if ARWR < $45 or IV > 120% or if unrealized loss on underlying >25%; accept assignment/buy at $65 (effective breakeven $52).
• If concerned about tail risk, implement defined‑risk Sep18 65/60 put spread (sell 65, buy 60) targeting net credit ≥ $8–$10 to cap max loss to $500 minus credit; position size 1–2% of portfolio and roll or close with >50% profit or if ARWR < $52.50.
• Buy 100 shares ARWR (~$66.54) and sell Sep18 70 covered call (collect ~$14 = $1,400) to target ~26% gross return if called; buy protective Sep18 62–60 put if unwilling to be assigned, or close/roll calls if stock rises >10% before expiry.
• Only purchase a Sep18 straddle (buy 65P + 70C, cost ≈ $27/$2,700) ahead of a known catalyst expected within 6 weeks and size ≤0.5% portfolio; require expected move >40% to justify cost and exit on 50% vol compression or 30% P/L target.